Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation This designation reflects Sanofi’s commitment to addressing a critical unmet need in ...

Regular physical activity is essential for maintaining a healthy lifestyle, especially for seniors. However, only some people are comfortable going to the gym or exercising outdoors, especially during ...

Selecting the appropriate nursing facility, also known as a nursing home, can be a challenging decision when considering the care of a parent. It’s important to recognize that no nursing home is ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

The healthcare sector has experienced significant transformations in recent years. From taking responsibility in critical situations to developing patient engagement platforms, healthcare ...

Conducted at Samsung Medical Center, the Phase 3 clinical trial enrolled 24 newly diagnosed Hunter Syndrome patients with no prior treatment. It evaluated the efficacy and safety of Hunterase over a ...

Nursing is a vital component of the healthcare sector. Nurses play a critical role in healthcare delivery. Their part in the medical care industry has become increasingly significant. They are ...

Access Medical Device News Magazine is easily accessible 24 hours a day, 7 days a week, and 365 days a year. It provides a fast and straightforward read that anyone can enjoy in just 1, 2, 3 easy ...

Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today significant financial support from Genome Canada and Genome Alberta ...

“Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly into the bloodstream. The global market for these technologies is growing due to ...

Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device ...

Black patients admitted to the hospital for labor and delivery are more likely to have stigmatizing language documented in their clinical notes than White patients, Columbia University School of ...